The global pharma & biotech CRM software market is estimated to reach USD 8,069 million by 2025 from USD 3,333.8 million in 2019 with a CAGR of 15.9%. Request To Download Sample of This Strategic ...

Below is Validea's guru fundamental report for SALESFORCE INC (CRM). Of the 22 guru strategies we follow, CRM rates highest using our Low PE Investor model based on the published strategy of John ...

We recently published a list of 10 AI Stocks on the Move. In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against other AI stocks on the move. Market ...

Customer relationship management software maker Salesforce (NYSE:CRM) will be reporting results ... Click here to access our ...

Let’s dig into the relative performance of Salesforce (NYSE:CRM) and its peers as we unravel the now-completed Q4 sales ...

Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Jefferies analyst Brent Thill maintained a Buy rating on Salesforce (CRM – Research Report) yesterday and set a price target of $375.00. The ...

Commissions do not affect our editors' opinions or evaluations. Customer relationship management (CRM) software can help businesses in numerous fields streamline customer interactions, improve ...

In a report released yesterday, Kirk Materne from Evercore ISI maintained a Buy rating on Salesforce (CRM – Research Report), with a price ...